Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (361-370 of 531) with videos related to

Pageof 54
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureusRobert J Kerns, Michael J Rybak, Glenn W Kaatz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 31, 2012
Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literatureD T Levy, M E Steed, M J Rybak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Pharmacotherapy|November 27, 2024
Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogensMohammed Al Musawa, Callan R Bleick, Shelbye R Herbin, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsGeorge Sakoulas, Monika Kumaraswamy, Poochit Nonejuie, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2021
Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatricsSean N Avedissian, Jennifer Le, Michael N Neely, et al.
Open Forum Infectious Diseases|April 11, 2019
The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With VancomycinEvan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Open Forum Infectious Diseases|July 25, 2019
The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With VancomycinEvan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2024
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an <i>ex vivo</i> simulated endocardial pharmacokinetic/pharmacodynamic modelAshlan J Kunz Coyne, Callan Bleick, Kyle Stamper, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISAB J Werth, C Vidaillac, K P Murray, et al.
Pageof 54

Showing results (361-370 of 531) with videos related to

Sort By:
Pageof 54
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureusRobert J Kerns, Michael J Rybak, Glenn W Kaatz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 31, 2012
Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literatureD T Levy, M E Steed, M J Rybak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Pharmacotherapy|November 27, 2024
Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogensMohammed Al Musawa, Callan R Bleick, Shelbye R Herbin, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsGeorge Sakoulas, Monika Kumaraswamy, Poochit Nonejuie, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2021
Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatricsSean N Avedissian, Jennifer Le, Michael N Neely, et al.
Open Forum Infectious Diseases|April 11, 2019
The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With VancomycinEvan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Open Forum Infectious Diseases|July 25, 2019
The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With VancomycinEvan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2024
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an <i>ex vivo</i> simulated endocardial pharmacokinetic/pharmacodynamic modelAshlan J Kunz Coyne, Callan Bleick, Kyle Stamper, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISAB J Werth, C Vidaillac, K P Murray, et al.
Pageof 54